Involving patients in the development of ATMPs is a key part of improving outcomes for patients. This webinar explores the rationale around why patient and public engagement is essential in the development of new therapies, focusing on the specific challenges and needs for cell and gene therapy and the benefits to patient and clinical outcomes when this work is done well.